Healthcare Professionals
-
News
TIF publishes new material on the COVID-10 Pandemic
TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2…
Read More » -
TIF Publications
A TIF-proposed Haemoglobinopathy Patient Pathway During the COVID-19 Pandemic (2020)
A Patient Care Pathway recommending adjustments to be implemented in the admission of patients to haemoglobinopathy centers, units, or clinics during the COVID-19 pandemic.
Read More » -
TIF News
The changing epidemiology of the ageing thalassaemia populations: A new position statement by TIF
Therapeutic advances in β-thalassaemia have gradually led to a significant improvement in prognosis over the past few decades. As a result, patients living in areas where disease specific programmes offer…
Read More » -
News
Novartis To Donate Up To 130 Million Doses Of Hydroxychloroquine To Treat Covid-19
On Friday, 20 March, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related…
Read More » -
TIF News
-
News
Clinical trials Updates – July 2017
Last update: July 2017 Luspatercept A novel agent that increases haemoglobin by promoting erythropoiesis. More specifically it promotes the differentiation and maturation of late-stage erythrocyte precursors by acting as a…
Read More » -
TIF Publications
Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT) (2nd Edition – 2017)
Ali T. Taher, MD PhD FRCP Khaled M. Musallam, MD PhD Maria Domenica Cappellini, MD FACP
Read More » -
TIF Publications
A Short Guide for the Management of Transfusion Dependent Thalassaemia (2017)
Prepared by: Farmakis, D. Angastiniotis, M. Eleftheriou, A.
Read More » -
Preceptorships
-
TIF News
